Literature DB >> 3087279

In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.

G J Noel, D W Teele.   

Abstract

The activities of six agents commonly used in treating infections of the skin and soft tissues and the action of selected cephalosporins against 15 isolates of Pasteurella multocida were assessed by a macro-broth dilution method. Broad-spectrum cephalosporins, including ceftriaxone and cefixime, had excellent in vitro activities (MIC less than or equal to 0.098) against the isolates tested.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3087279      PMCID： PMC176407          DOI： 10.1128/AAC.29.2.344

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Pasteurella multocida. Infections after domestic animal bites and scratches.

Authors:  D P Francis; M A Holmes; G Brandon
Journal:  JAMA       Date:  1975-07-07       Impact factor: 56.272

2.  Pasteurella multocida infections following animal injuries, especially cat bites.

Authors:  J P Tindall; C M Harrison
Journal:  Arch Dermatol       Date:  1972-03

3.  Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole.

Authors:  S I Pelton; P A Shurin; J O Klein; M Finland
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

4.  Neonatal septicemia and meningitis due to Pasteurella multocida.

Authors:  C M Thompson; L Pappu; A H Levkoff; K H Herbert
Journal:  Pediatr Infect Dis       Date:  1984 Nov-Dec

Review 5.  Pasteurella multocida infection; report in urban setting and review of spectrum of human disease.

Authors:  R A Furie; R P Cohen; B J Hartman; R B Roberts
Journal:  N Y State J Med       Date:  1980-09

6.  Antibiotic susceptibilities of human isolates of Pasteurella multocida.

Authors:  D L Stevens; J W Higbee; T R Oberhofer; E D Everett
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

7.  Pasteurella multocida. Osteomyelitis following dog bites.

Authors:  W R Jarvis; S Banko; E Snyder; R S Baltimore
Journal:  Am J Dis Child       Date:  1981-07

Review 8.  Pasteurella multocida infections. Report of 34 cases and review of the literature.

Authors:  D J Weber; J S Wolfson; M N Swartz; D C Hooper
Journal:  Medicine (Baltimore)       Date:  1984-05       Impact factor: 1.889

9.  Unusual infections caused by Pasteurella multocida.

Authors:  R H Johnson; L W Rumans
Journal:  JAMA       Date:  1977-01-10       Impact factor: 56.272

10.  Pasteurella multocida septicemia. Experience at a cancer hospital.

Authors:  A A Stein; M A Fialk; A Blevins; D Armstrong
Journal:  JAMA       Date:  1983-01-28       Impact factor: 56.272
  10 in total
  5 in total

1.  Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida.

Authors:  E J Goldstein; D M Citron; G A Richwald
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

Review 2.  Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.

Authors:  R N Brogden; D M Campoli-Richards
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

3.  A novel apidaecin Api-PR19 synergizes with the gut microbial community to maintain intestinal health and promote growth performance of broilers.

Authors:  Shengru Wu; Jian Wang; Liqin Zhu; Hao Ren; Xiaojun Yang
Journal:  J Anim Sci Biotechnol       Date:  2020-06-17

4.  Infantile Pasteurella multocida meningitis.

Authors:  Jones T Nauseef; Nathan B Price; Kelly E Wood
Journal:  IDCases       Date:  2016-09-20

5.  Bacteremic meningitis due to Pasteurella multocida resistant to first line antibiotic therapy.

Authors:  Damiano Larnè; Manuela Ceccarelli; Fabrizio Condorelli; Emmanuele Venanzi Rullo; Giuseppe Nunnari; Giovanni Francesco Pellicanò
Journal:  Infect Dis Rep       Date:  2018-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.